Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Knowledge Sourcing Intelligence | PRODUCT CODE: 2021331

Cover Image

PUBLISHER: Knowledge Sourcing Intelligence | PRODUCT CODE: 2021331

Lab Automation Market - Strategic Insights and Forecasts (2026-2031)

PUBLISHED:
PAGES: 148 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 3950
PDF & Excel (Multi User License - Up to 5 Users)
USD 4550
PDF & Excel (Enterprise License)
USD 6950

Add to Cart

The Lab Automation market is forecast to grow at a CAGR of 8.8%, reaching USD 11.9 billion in 2031 from USD 7.8 billion in 2026.

The global lab automation market is strategically positioned as a core enabler of efficiency and precision across life sciences, diagnostics, and pharmaceutical research. The increasing complexity of laboratory workflows, coupled with the need for high-throughput screening and rapid diagnostics, is driving the transition toward automated systems. Laboratories are under pressure to deliver accurate and reproducible results while managing rising sample volumes. This has accelerated the adoption of automation technologies that integrate robotics, artificial intelligence, and data analytics. In parallel, growing investments in biotechnology research and clinical diagnostics are reinforcing the long-term demand for advanced lab automation solutions.

Market Drivers

A key driver of market growth is the rising demand for operational efficiency and productivity in laboratories. Automated systems significantly reduce manual intervention, enabling faster processing of samples and minimizing human error. This is particularly critical in pharmaceutical and biotechnology research, where precision and reproducibility are essential.

The increasing gap between the availability of skilled laboratory personnel and the growing workload is another major factor supporting adoption. Automation helps address workforce shortages by streamlining repetitive tasks such as pipetting, sample preparation, and data handling. Additionally, the surge in drug discovery activities and clinical testing has amplified the need for high-throughput automated platforms.

Government funding and policy support for life sciences research further contribute to market expansion. Investments in healthcare infrastructure and diagnostic capabilities, especially in emerging economies, are accelerating the deployment of automated laboratory systems.

Market Restraints

Despite strong growth prospects, the market faces challenges related to high initial capital investment. The implementation of automated systems requires significant expenditure on equipment, integration, and maintenance, which can limit adoption among small and medium-sized laboratories.

Integration complexity is another restraint. Laboratories often operate with legacy systems and diverse workflows, making the transition to fully automated environments technically challenging. Additionally, the need for specialized training to operate advanced systems can slow adoption rates.

Technology and Segment Insights

The market is segmented by product, automation type, application, and end-user. Product segments include automated workstations, robotic systems, microplate readers, and software solutions. Automated liquid handling systems and integrated workstations represent key components due to their role in streamlining laboratory workflows.

By automation type, total laboratory automation systems dominate the market, driven by their ability to handle high sample volumes with minimal human intervention. Modular automation systems are gaining traction due to their flexibility and scalability, allowing laboratories to automate specific processes incrementally.

Application segments include drug discovery, clinical diagnostics, and environmental testing. Clinical chemistry and immunoassay analysis represent significant areas of adoption due to the need for high accuracy and throughput. End-users include pharmaceutical and biotechnology companies, academic and research institutes, and diagnostic laboratories.

Competitive and Strategic Outlook

The competitive landscape is characterized by the presence of established global players focusing on innovation and strategic expansion. Companies such as Thermo Fisher Scientific, Danaher, Agilent Technologies, and Roche are investing in advanced automation platforms that integrate AI and data analytics capabilities.

Strategic initiatives include mergers and acquisitions, partnerships with research institutions, and the development of modular and scalable solutions. Companies are also focusing on enhancing interoperability and cloud integration to improve workflow efficiency and data management.

Conclusion

The global lab automation market is set for steady growth, supported by increasing demand for efficiency, rising research activities, and technological advancements. While high costs and integration challenges remain key barriers, continuous innovation and expanding applications across industries will sustain long-term market growth.

Key Benefits of this Report

  • Insightful Analysis: Gain detailed market insights across regions, customer segments, policies, socio-economic factors, consumer preferences, and industry verticals.
  • Competitive Landscape: Understand strategic moves by key players to identify optimal market entry approaches.
  • Market Drivers and Future Trends: Assess major growth forces and emerging developments shaping the market.
  • Actionable Recommendations: Support strategic decisions to unlock new revenue streams.
  • Caters to a Wide Audience: Suitable for startups, research institutions, consultants, SMEs, and large enterprises.

What Businesses Use Our Reports For

Industry and market insights, opportunity assessment, product demand forecasting, market entry strategy, geographical expansion, capital investment decisions, regulatory analysis, new product development, and competitive intelligence.

Report Coverage

  • Historical data from 2021 to 2025 and forecast data from 2026 to 2031
  • Growth opportunities, challenges, supply chain outlook, regulatory framework, and trend analysis
  • Competitive positioning, strategies, and market share evaluation
  • Revenue growth and forecast assessment across segments and regions
  • Company profiling including strategies, products, financials, and key developments
Product Code: KSI061615923

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. LAB AUTOMATION MARKET BY PROCESS

  • 5.1. Introduction
  • 5.2. Continuous Flow
  • 5.3. Discrete Flow

6. LAB AUTOMATION MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Photometry and Fluorometry
  • 6.3. Immunoassay Analysis
  • 6.4. Electrolyte Analysis
  • 6.5. Others

7. LAB AUTOMATION MARKET BY AUTOMATION

  • 7.1. Introduction
  • 7.2. Total Automation Systems
  • 7.3. Modular Automation Systems

8. LAB AUTOMATION MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. QIAGEN
  • 10.2. PerkinElmer Inc.
  • 10.3. Thermo Fisher Scientific, Inc.
  • 10.4. Siemens Healthcare GmbH
  • 10.5. Danaher
  • 10.6. Agilent Technologies, Inc.
  • 10.7. Eppendorf SE
  • 10.8. Hudson Robotics
  • 10.9. Aurora Biomed Inc.
  • 10.10. BMG LABTECH GmbH

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key benefits for the stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!